TrialDiabetes, obesity & metabolism2026

Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial.

Teruki Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.